Initiating Lithium in Patients with Losartan and Omeprazole

Critical Drug Interactions and Monitoring

The American Heart Association suggests that losartan 50mg daily represents a moderate dose, with a typical range of 50-100mg daily for hypertension 1, 2, 3
The American College of Cardiology recommends monitoring for losartan-induced renal dysfunction, which is reversible upon discontinuation, with a significant risk of lithium toxicity in patients with reduced creatinine clearance (<50 mL/min) 1, 2, 3
The European Society of Cardiology indicates that omeprazole 40mg daily does not have documented significant interactions with lithium and does not require dose adjustment, but may cause potential hypomagnesemia with chronic use, which could indirectly affect lithium monitoring 6

The American Academy of Child and Adolescent Psychiatry recommends obtaining complete blood count, thyroid function tests (TSH, free T4), urinalysis, blood urea nitrogen and serum creatinine, serum calcium, and serum electrolytes including potassium before starting lithium 4, 5, 6, 7
The American College of Cardiology suggests that patients with creatinine clearance <50 mL/min have significantly higher risk of lithium toxicity even at therapeutic doses, requiring careful monitoring 4, 5

The American College of Cardiology recommends beginning with lower-than-standard lithium doses given the losartan interaction risk, with a standard starting dose of typically 300mg twice daily, but considering 300mg once or twice daily initially in this patient 6
The American Academy of Child and Adolescent Psychiatry suggests targeting a therapeutic lithium level of 0.6-1.0 mEq/L for maintenance (acute mania may require 0.8-1.2 mEq/L) 4

The European Society of Cardiology recommends checking serum lithium levels 5-7 days after initiation, then weekly until stable, and monitoring renal function (creatinine, BUN) and electrolytes within 2-3 days, then at 7 days, then weekly 6
The American College of Cardiology suggests monitoring lithium levels every 1-2 weeks during dose adjustments, and every 3-6 months during the maintenance phase, with renal function, electrolytes, thyroid function, and urinalysis every 3-6 months 4

The American Heart Association indicates that losartan can affect renal function similarly to ACE inhibitors, potentially causing acute renal dysfunction in 10.5% of elderly heart failure patients, and recommends avoiding additional interacting medications such as NSAIDs, thiazide or loop diuretics, and additional ACE inhibitors or dual RAS blockade 1, 2, 5
The European Society of Cardiology suggests monitoring potassium levels closely, especially if creatinine clearance <50 mL/min, and discontinuing any potassium supplements, avoiding potassium-sparing diuretics or aldosterone antagonists 6, 1, 2